Clinical Trial Update: An Open-label Study of KW-3357 [Phase 3]

View source ↗

Summary

An open-label Phase 3 trial of KW-3357 for disseminated intravascular coagulation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disseminated Intravascular Coagulation

Drugs mentioned

• KW-3357

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Disseminated Intravascular Coagulation (DIC) | Phase 3 | Status: COMPLETED